Myelodysplastic Syndrome

	05/14/2009	Applying Key Biomarkers in Oncology: From Biospecimen Preparation and Storage to Clinical Implications
	04/22/2009	Evaluating New Data in Iron Overload: Updates on Chelation Therapy in Transfusional Disease
	03/20/2009	Bone Marrow Failure Syndromes Optimizing Outcomes Worldwide through Disease Understanding
	03/03/2009	Exploring New Trends in MDS & AML: From Clinical Data in Poor-Prognosis Patients to Mechanisms of Novel Agents
	03/03/2009	Interpreting New Findings on Epigenetic Changes in MDS and AML-What Impact Will They Have on Treatment?
	03/03/2009	Do Modified Treatment and Novel Therapies Augment Clinical Benefit in AML?
	03/03/2009	Crafting an Individualized Approach to MDS Therapy: New Data on Prognostic Models and Management of Higher Risk Disease
	02/16/2009	Hematology Data Update From San Francisco: Emerging Clinical Trends Across Malignant Settings
	08/25/2008	Clinical Implications of New Data on Iron Overload in Patients With MDS
	08/25/2008	Practical Implications of New Canadian Guidelines on Treating Iron Overload in MDS
	08/25/2008	Effective and Safe Iron Chelation Therapy for Iron Overloaded Patients With Myelodysplastic Syndromes
	08/25/2008	Considerations for Optimal Patient Management of Iron Overload
	05/12/2008	Epigenetic Alterations as Targets of Therapy in Myelodysplastic Syndromes: Applying Science to Clinical Practice
	05/12/2008	Epigenomic Modification as a Therapeutic Strategy in Myelodysplasia: What Is the Rationale?
	05/12/2008	DNA Hypomethylating Agents Can Alter Natural History of Myelodysplastic Syndromes
	05/12/2008	DNA Hypomethylating Agents Associated With Manageable Toxicities in the Treatment of Myelodysplasia
	03/24/2008	New Classification Systems and Therapies Instigate Evolving Diagnostic and Treatment Models of MDS
	02/28/2008	State of the Science in MDS: Update on Diagnosis, Evaluation, and Treatment
	02/28/2008	New Data Help Clarify Role of Prognostic Factors in MDS
	02/28/2008	Can New Treatments Prolong Survival in Patients With Myelodysplastic Syndromes?
	02/28/2008	Cytogenetic/Molecular Testing and Experimental Therapies for MDS: What Does the Latest Evidence Show?